{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:11Z","timestamp":1767134891121,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":43,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006974.pub3","type":"reference-entry","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T15:32:32Z","timestamp":1341588752000},"source":"Crossref","is-referenced-by-count":1,"title":["Hematopoietic stem cell transplantation for Gaucher disease"],"prefix":"10.1002","author":[{"given":"Usha Rani","family":"Somaraju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Tadepalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"10.1002\/14651858.CD006974.pub3-BIB1|cit1","series-title":"Proceedings of the 8th European Working Group on Gaucher Disease (EWGGD); 2008 June 4-7; Budapest, Hungary","first-page":"18","article-title":"Novel enzyme replacement therapy for Gaucher disease; on-going phase 3 clinical trial with recombinant human glucocerebrosidase expressed in plant cells [abstract]","author":"Almon","year":"2008"},{"key":"10.1002\/14651858.CD006974.pub3-BIB2|cit2","unstructured":"Baker KS Study of pulmonary complications in Pediatric Patients With Storage Disorders undergoing Allogeneic Hematopoietic stem cell transplantation www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD006974.pub3-BIB3|cit3","unstructured":"Barranger J Phase I study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene into peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher disease www.clinicaltrials.gov"},{"issue":"2","key":"10.1002\/14651858.CD006974.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3324\/haematol.10635","article-title":"Low frequency maintenance therapy with imiglucerase in adult type 1 Gaucher disease: a prospective randomised controlled trial","volume":"92","author":"Fost","year":"2007","journal-title":"Haematologica"},{"issue":"7","key":"10.1002\/14651858.CD006974.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/qjmed\/91.7.483","article-title":"Low-dose low frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type 1 Gaucher disease","volume":"91","author":"Elstein","year":"1998","journal-title":"QJM:Monthly Journal of the Association of Physicians"},{"key":"10.1002\/14651858.CD006974.pub3-BIB6|cit6","series-title":"Proceedings of the 6th Meeting of the European Hematology Association","first-page":"Abst 212","article-title":"OGT918 as substrate reduction therapy in type 1 gaucher disease [abstract]","author":"Elstein","year":"2001"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006974.pub3-BIB7|cit7","first-page":"S139, Abstract","article-title":"Clinically significant hemoglobin response observed within 3 months following treatment with velaglucerase alfa in patients with type 1 gaucher disease [abstract]","volume":"33","author":"Gonzales","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD006974.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in gaucher diseasetype1: comparative efficacy of mannose terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD006974.pub3-BIB9|cit9","doi-asserted-by":"crossref","unstructured":"Kishnani PS DiRocco M Kaplan P Mehta A Pastores GM Smith SE A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1 Molecular Genetics and Metabolism 2009 164 70","DOI":"10.1016\/j.ymgme.2008.12.015"},{"key":"10.1002\/14651858.CD006974.pub3-BIB10|cit10","unstructured":"Mehta A A multicentre, randomised, dose frequency study of the safety and efficacy of cerezyme infusions every 4 weeks versus every 2 weeks in the maintenance therapy of patients with type 1 gaucher disease [abstract] Proceedings of the 8th European Working Group on Gaucher Disease (EWGGD); 2008 June 4-7th; Budapest, Hungary 2008 11"},{"key":"10.1002\/14651858.CD006974.pub3-BIB11|cit11","unstructured":"Orchard P Treatment of Lysosomal and Peroxisomal Inborn Errors of Metabolism by Bone Marrow Transplantation www.clinicaltrials.gov"},{"key":"10.1002\/14651858.CD006974.pub3-BIB12|cit12","doi-asserted-by":"crossref","unstructured":"Schiffmann R Fitzgibbon EJ Harris C DeVile C Davies EH Abel L Randomized, controlled trial of miglustat in Gaucher's disease type 3 Annals of Neurology 2008 514 22","DOI":"10.1002\/ana.21491"},{"key":"10.1002\/14651858.CD006974.pub3-BIB13|cit13","first-page":"Abstract 427-P","article-title":"A phase 2 clinical trials of the pharmacological chaperone AT2101 for the treatment of Gaucher disease [abstract]","volume":"108","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD006974.pub3-BIB14|cit14","series-title":"Proceedings of the 8th European Working Group on Gaucher Disease (EWGGD); 2008 June 4-7; Budapest, Hungary","first-page":"14","article-title":"A phase 2 clinical trial of the pharmacological chaperone AT2101 for the treatment of gauchers disease [abstract]","author":"Weinreb","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD006974.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD006974.pub3-BIB16|cit16","doi-asserted-by":"crossref","unstructured":"Zimran A Brill-Almon E Chertkoff R Petakov M Blanco-Favela F Munoz ET Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease Blood 2011 5767 73","DOI":"10.1182\/blood-2011-07-366955"},{"key":"10.1002\/14651858.CD006974.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"236A","DOI":"10.1203\/00006450-198404001-00856","article-title":"Bone marrow transplantation (BMT) in Gaucher's disease","volume":"18","author":"August","year":"1984","journal-title":"Paediatric Research"},{"key":"10.1002\/14651858.CD006974.pub3-BIB18|cit18","first-page":"3635","article-title":"Gaucher Disease","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","volume":"III","author":"Beutler","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD006974.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0971-6866.19530","article-title":"The treatment of Gaucher disease in countries with limited health care resources","volume":"11","author":"Beutler","year":"2005","journal-title":"Indian Journal of Human Genetics"},{"key":"10.1002\/14651858.CD006974.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","article-title":"Gaucher disease: multiple lessons from a single gene disorder","volume":"Suppl 451","author":"Beutler","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"2","key":"10.1002\/14651858.CD006974.pub3-BIB21|cit21","first-page":"327","article-title":"Bone marrow transplantation in Gaucher's disease: effect of mixed chimeric state","volume":"14","author":"Chan","year":"1994","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006974.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00005792-199511000-00002","article-title":"Gaucher Disease","volume":"74","author":"Danuta","year":"1995","journal-title":"Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006974.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2008-1071549","article-title":"Enzyme replacement therapy of infantile Gaucher disease","volume":"24","author":"Erikson","year":"1993","journal-title":"Neuropediatrics"},{"issue":"7414","key":"10.1002\/14651858.CD006974.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006974.pub3-BIB25|cit25","unstructured":"Higgins JPT Altman DG (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org"},{"issue":"8542","key":"10.1002\/14651858.CD006974.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(87)91673-4","article-title":"Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome","volume":"1","author":"Hobbs","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD006974.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2141.2004.05351.x","article-title":"Gaucher disease: pathological mechanisms and modern management","volume":"129","author":"Jmoudiak","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"3","key":"10.1002\/14651858.CD006974.pub3-BIB28|cit28","first-page":"128","article-title":"Haematopoietic stem cell transplantation: current status","volume":"20","author":"Kumar","year":"2007","journal-title":"National Medical Journal of India"},{"key":"10.1002\/14651858.CD006974.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejim.2006.07.005","article-title":"Epidemiology and natural history of Gaucher's disease","volume":"17","author":"Mehta","year":"2006","journal-title":"European Journal of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006974.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/106002809603000411","article-title":"Gaucher's Disease: A Review","volume":"30","author":"Morales","year":"1996","journal-title":"Annals of Pharmacotherapy"},{"issue":"24","key":"10.1002\/14651858.CD006974.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival end-points","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006974.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Haematopoietic stem cell transplantation for Inherited metabolic diseases: an overview of outcomes and practice guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006974.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1056\/NEJM198407123110203","article-title":"Bone-marrow transplantation In severe Gaucher's disease","volume":"311","author":"Rappeport","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006974.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-198807000-00011","article-title":"Long-term follow-up of the first successful Bone marrow transplantation in Gaucher disease","volume":"46","author":"Ringden","year":"1988","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD006974.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00007890-199503000-00011","article-title":"Ten years experience of bone marrow transplantation for gaucher disease","volume":"59","author":"Ringden","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD006974.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.11193","article-title":"Therapy of adult Gaucher disease","volume":"92","author":"Schmitz","year":"2007","journal-title":"Haematologica"},{"issue":"720","key":"10.1002\/14651858.CD006974.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1259\/0007-1285-60-720-1189","article-title":"Regression of the radiological changes of Gaucher's disease following bone marrow transplantation","volume":"60","author":"Starer","year":"1987","journal-title":"British Journal of Radiology"},{"issue":"12","key":"10.1002\/14651858.CD006974.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/adc.2005.074278","article-title":"Haemopoietic stem cell transplantation for genetic disorders","volume":"90","author":"Steward","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"4-5","key":"10.1002\/14651858.CD006974.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000112184","article-title":"Norbottnian type of Gaucher disease - Clinical, Biochemical and Molecular Biology aspects: Successful treatment with Bone marrow transplantation","volume":"13","author":"Svennerholm","year":"1991","journal-title":"Developmental Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD006974.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1203\/00006450-199205000-00019","article-title":"Allogeneic Bone marrow transplantation in Severe Gaucher disease","volume":"31","author":"Tsai","year":"1992","journal-title":"Pediatric Research"},{"issue":"4","key":"10.1002\/14651858.CD006974.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1005367328003","article-title":"Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase","volume":"20","author":"Young","year":"1997","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"8947","key":"10.1002\/14651858.CD006974.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(95)90432-8","article-title":"Enzyme replacement therapy in type 1 and type 3 Gaucher's disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD006974.pub3-BIB43|cit43","article-title":"Hematopoietic stem cell transplantation for Gaucher disease","author":"Somaraju","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006974.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006974.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:05:52Z","timestamp":1628532352000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006974.pub3"}},"subtitle":[],"editor":[{"given":"Usha Rani","family":"Somaraju","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":43,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006974.pub3","relation":{},"subject":[],"published":{"date-parts":[[2012,7,11]]}}}